undefined

Posts

undefined

Followers

User since undefined NaN
Health

FDA to Consider MDMA as a Potential Treatment for PTSD

2023-12-13
video by 4 News Now

Takeaways:

• The US Food and Drug Administration (FDA) has been asked to review MDMA, the active ingredient in drugs like ecstasy and molly, as a potential treatment for post-traumatic stress disorder (PTSD).

• The application was filed by the MAPS Public Benefit Corporation, which has been studying the drug in combination with therapy to treat PTSD.

• In 2017, the FDA granted MDMA-assisted therapy a breakthrough therapy designation, which expedites the development and review of drugs intended to treat serious conditions.

• Two studies have shown that MDMA significantly reduced symptoms and impairment associated with PTSD compared with a placebo. MAPS has completed six late-stage clinical trials testing MDMA for PTSD.

• If the FDA approves MDMA for this purpose, it would need to be rescheduled, as it is currently a schedule I drug under the Controlled Substances Act, defined as having no currently accepted medical use.

References:

[1] FDA may review MDMA for the treatment of PTSD. Link

This article is generated with AI assistance. AI enhances user experience by providing more comprehensive and detailed content, yet there remains a slight risk of encountering inaccuracies on rare occasions. Agree to access AI-generated content by clicking here, or opt for content with less AI influence here.

https://img.particlenews.com/image.php?url=3q9B11_0qCd7LxJ00
emoji_like
emoji_angry
emoji_wow
30

Comments